Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
1. Novavax's vaccine received FDA approval with age and condition restrictions. 2. Research on heart conditions is a requirement for Novavax's vaccine. 3. The approval triggers a $175 million payment from partner Sanofi. 4. Analysts predict better market share due to Sanofi's distribution strength. 5. FDA plans a major approach meeting, impacting future vaccine approvals.